MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study

Authors: Mark C. Genovese, Mario Berkowitz, Philip G. Conaghan, Charles Peterfy, Katherine Davy, Elena Fisheleva, Anubha Gupta, David R. Inman, Robert L. Janiczek, Mark Layton, Nina Mitchell, Jatin Patel, Alexandra H. Roberts, Didier Saurigny, Julia E. Smith, R. Williamson, Paul P. Tak - The Lancet 2020 cited by 27